Biomarkers Market Set To Grow At Rapid Pace Till 2024 – Global Industry Share, SWOT Analysis, Leading Players Profile, Strategic Outlook And Application Estimates | Million Insights

April 23 06:41 2021
Biomarkers Market Set To Grow At Rapid Pace Till 2024 - Global Industry Share, SWOT Analysis, Leading Players Profile, Strategic Outlook And Application Estimates | Million Insights

Million Insights – World’s Fastest Growing Market Research Database
According to new report available with Million Insights, the global biomarker industry report provides a detailed analysis of global market size, regional and country-level market size, competitive landscape, impact of domestic market players and value chain optimization. Biomarkers Market is segmented by types, manufacturers, applications and regions.

The global Biomarkers Market size is expected to value at USD 78.2 billion by 2024. The market is subject to witness a substantial growth due to the growing adoption of the biomarkers in the drug discovery and development along with growing R&D expenditure. Biomarkers are considered as quantifiable molecular alterations that are implemented for the development of highly precise and efficient therapeutic targets.

Factors responsible for the robust market growth of biomarkers, in the recent years, include prevalence of oncology, neurology, and cardiology-related disorders across the globe. Globally, the biomarkers industry is predicted to grow at higher CAGR over the forecast period, providing numerous opportunities for market players to invest in research and development of the market.

The recent technological advancement coupled with the development of novel products and techniques such as biomarker based-diagnostics are expected to fuel the growth of biomarkers market over the forecast period. Additionally, introduction of advanced diagnostic methods along with higher precision and sensitivity are projected to drive market growth in the upcoming years.

To download the sample pdf of Biomarkers Market Report “Please” click here:

Growing implementation of number of safety biomarkers and increasing approval rate by local and international authorities are predicted to foster market growth in the near future. Development of innovative products such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST), which are capable of detecting toxicity in the kidney and liver, is propelling market demand for biomarker, in the last few years.

Substantial increase in occurrence of infectious diseases coupled with favorable government initiatives to promote early use of various diagnostic platforms in the developing and developed economies are estimated to positively influence market performance of biomarkers. Recent funding for research & development of the early and timely diagnosis of asymptomatic disorders like hemoglobinopathies are stimulating market expansion, in the recent years. For example, introduction of the Fetal Hemoglobin mAb test kit to identify HbF in infants born to sickle cell carrier parents are fostering market demand for biomarkers.

The biomarkers industry is broadly categorized into three major types based on the product type such as safety biomarkers, efficacy biomarkers, and validation biomarkers. The safety biomarkers is considered as one of the fastest growing segment in the market with substantial revenue generation in the last couple of years. Growing popularity of the safety biomarker market segment is attributed to the rising health consciousness among general population and growing number of routine healthcare checkups.

Other factors fostering market demand for safety biomarkers include growing base of the high-risk population for various diseases, the determination of patient subset specific to a certain molecular profile, and the associated targeted therapy. In addition, declining drug attrition rate regarding biomarker-based therapy is driving the market growth of safety biomarkers segment.

The validation biomarkers have also witnessed massive growth, in the recent years owing to increasing deployment rate by pharmaceutical companies for the pharmacogenomics approach to identify therapeutic failure of the novel drugs. Increasing adoption of identification of the non-responder patient subsets consisting of distinct genetic profiles with low therapeutic response is stimulating market growth of validation segment.

The biomarkers industry is divided by region as North America, Europe, Asia-Pacific, Latin America and Africa. North America has shown major growth in recent years owing to the rise in the implementation of latest technologies in medicine & pharmaceutical sector, increase in the R&D funding for drug discovery and testing, the high patient awareness levels regarding the availability of enhanced diagnostics techniques, and existence of well-established healthcare infrastructure in the region.

Asia-Pacific region is predicted to hold major market share in the biomarkers market with massive growth in forecast period. Countries such as India, China and Singapore are leading the Asia-Pacific market with increasing target population, strong economic growth, declining cost of clinical trials, rising healthcare infrastructure activities, and significant investment by leading industry players considering potential growth opportunities in the region.

The key players in the biomarker industry are Roche Diagnostics Limited, Abbott Laboratories Incorporations, Agilent Technologies Incorporations, Epigenomics Inc., GE Healthcare, Inc., Johnson & Johnson Co., Thermo Fisher Scientific Incorporations, Bio-Rad Laboratories Incorporations, Siemens Healthcare GmbH, Qiagen N.V., and Merck& Co., Inc.

To browse report summary & detailed TOC, “please” click the link below:

Market Segment:

Global Biomarkers Type Outlook (Revenue, USD Million, 2013 – 2024)
    • Safety
    • Efficacy
    • Validation

Global Biomarkers Application Outlook (Revenue, USD Million, 2013 – 2024)
    • Diagnostic
    • Drug Development
    • Personalized Medicine
    • Others

Global Biomarkers Disease Outlook (Revenue, USD Million, 2013 – 2024)
    • Oncology
    • Cardiovascular disease
    • Neurological disease
    • Immunological disease
    • Others

Biomarkers Regional Outlook (Revenue, USD Million, 2013 – 2024)
    • North America
        • U.S.
        • Canada
    • Europe
        • UK
        • Germany
        • France
        • Spain
        • Italy
    • Asia Pacific
        • Japan
        • China
        • India
    • Latin America
        • Brazil
        • Mexico
    • MEA
        • South Africa

Read the Latest Market Research Reports by Million Insights:

• Telemedicine Market: With reference to the report published, the global telemedicine market size was prized by USD 55.9 billion in 2020. It is estimated to witness 22.4% CAGR from 2021 to 2028.

• Rubber Gloves Market: With reference to the report published, the global rubber gloves market size was prized by USD 7.4 billion in 2019. It is estimated to witness 14.7% CAGR from 2020 to 2027.

 About Million Insights

Million Insights, is a distributor of market research reports, published by premium publishers only. We have a comprehensive market place that will enable you to compare data points, before you make a purchase. Enabling informed buying is our motto and we strive hard to ensure that our clients get to browse through multiple samples, prior to an investment. Service flexibility & the fastest response time are two pillars, on which our business model is founded. Our market research report store, includes in-depth reports, from across various industry verticals, such as healthcare, technology, chemicals, food & beverages, consumer goods, material science & automotive.

Media Contact
Company Name: Million Insights
Contact Person: Ryan Manuel
Email: Send Email
Phone: 91-20-65300184
Address:Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar
City: Pune
State: Maharashtra
Country: India

Warning: count(): Parameter must be an array or an object that implements Countable in /home/haridwartoday/ on line 7